Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orofaciodigital Syndromes | 1 | 2020 | 23 | 0.760 |
Why?
|
| Coronary Occlusion | 1 | 2023 | 303 | 0.700 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2020 | 186 | 0.670 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 315 | 0.610 |
Why?
|
| Coronary Stenosis | 2 | 2019 | 834 | 0.560 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2019 | 279 | 0.540 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 1486 | 0.470 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 1941 | 0.370 |
Why?
|
| Doxorubicin | 3 | 2014 | 2215 | 0.170 |
Why?
|
| Sonication | 1 | 2019 | 83 | 0.170 |
Why?
|
| Sarcoma, Synovial | 1 | 2019 | 164 | 0.160 |
Why?
|
| Furosemide | 1 | 2018 | 167 | 0.150 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2018 | 173 | 0.150 |
Why?
|
| Leptospirosis | 1 | 2016 | 29 | 0.140 |
Why?
|
| Prosthesis Design | 1 | 2023 | 2110 | 0.140 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 374 | 0.130 |
Why?
|
| Diuretics | 1 | 2018 | 591 | 0.130 |
Why?
|
| Edema | 1 | 2018 | 790 | 0.120 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 846 | 0.110 |
Why?
|
| Diterpenes | 1 | 2014 | 173 | 0.110 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 316 | 0.110 |
Why?
|
| Aortic Valve | 1 | 2023 | 1911 | 0.110 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1015 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2023 | 62966 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 279 | 0.110 |
Why?
|
| Dopamine | 1 | 2018 | 1589 | 0.100 |
Why?
|
| Dyspnea | 1 | 2018 | 1298 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 491 | 0.090 |
Why?
|
| Antibodies | 1 | 2017 | 2459 | 0.080 |
Why?
|
| Troponin | 1 | 2012 | 524 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2008 | 103 | 0.080 |
Why?
|
| Organotechnetium Compounds | 1 | 2008 | 137 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2019 | 3099 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2217 | 0.080 |
Why?
|
| Registries | 1 | 2023 | 8077 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 2012 | 1585 | 0.070 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2008 | 153 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2019 | 5978 | 0.070 |
Why?
|
| Contrast Media | 1 | 2019 | 5295 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2016 | 3461 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 434 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 1636 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3861 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2007 | 692 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2018 | 6483 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1107 | 0.050 |
Why?
|
| Insulin | 1 | 2017 | 6575 | 0.050 |
Why?
|
| Humans | 11 | 2023 | 742088 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2014 | 2789 | 0.050 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 105 | 0.040 |
Why?
|
| Microbubbles | 1 | 2019 | 128 | 0.040 |
Why?
|
| Transducers | 1 | 2019 | 252 | 0.040 |
Why?
|
| Heart Failure | 2 | 2018 | 10856 | 0.040 |
Why?
|
| Heart | 2 | 2008 | 4462 | 0.040 |
Why?
|
| Leptospira | 1 | 2016 | 11 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2007 | 2410 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 1437 | 0.040 |
Why?
|
| Azathioprine | 1 | 2017 | 355 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 1420 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 1912 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2018 | 924 | 0.030 |
Why?
|
| Gadolinium | 1 | 2019 | 951 | 0.030 |
Why?
|
| Female | 9 | 2019 | 379592 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 11695 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2018 | 2271 | 0.030 |
Why?
|
| Random Allocation | 2 | 2008 | 2425 | 0.030 |
Why?
|
| Creatinine | 1 | 2018 | 1916 | 0.030 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 753 | 0.030 |
Why?
|
| Myofibrils | 1 | 2012 | 146 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2019 | 1873 | 0.030 |
Why?
|
| Echocardiography | 2 | 2018 | 5097 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 2236 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13655 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2017 | 1949 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2014 | 1458 | 0.020 |
Why?
|
| Male | 4 | 2019 | 349538 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 1723 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 828 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2012 | 586 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1575 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2107 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7141 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3689 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 643 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 20774 | 0.020 |
Why?
|
| Aspirin | 1 | 2018 | 3278 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2007 | 201 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 8300 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3557 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2018 | 4983 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2007 | 319 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10943 | 0.020 |
Why?
|
| Myocardium | 2 | 2008 | 4775 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 213127 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4147 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 2335 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6608 | 0.010 |
Why?
|
| Cell Death | 1 | 2008 | 1695 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2012 | 8436 | 0.010 |
Why?
|
| Rats | 2 | 2008 | 24265 | 0.010 |
Why?
|
| Animals | 4 | 2019 | 168561 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5753 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6365 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7153 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16665 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39004 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20086 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 35342 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 29717 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18006 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 81045 | 0.000 |
Why?
|
| Aged | 1 | 2018 | 162944 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 213712 | 0.000 |
Why?
|
Concepts
(113)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_